"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente-Oakland conducted 244 clinical trials. In the 10-year time frame, 244 clinical trials started and 191 clinical trials were completed, i.e. on average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 105 clinical trials were completed. i.e. 118% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Oakland" #1 sponsor was "National Cancer Institute (NCI)" with 123 trials, followed by "Children's Oncology Group" with 100 trials sponsored, "SWOG Cancer Research Network" with 47 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored and "Kaiser Permanente" with 27 trials sponsored. Other sponsors include 144 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Oakland" #1 collaborator was "National Cancer Institute (NCI)" with 236 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Kaiser Permanente" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator and "Children's Oncology Group" with 10 trials as a collaborator. Other collaborators include 225 different institutions and companies that were collaborators in the rest 152 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Oakland" are "Breast Cancer" (27 trials), "Recurrent Neuroblastoma" (20 trials), "Recurrent Malignant Solid Neoplasm" (15 trials), "Recurrent Osteosarcoma" (15 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Kaiser Permanente-Oakland" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Oakland" are "Drug" (327 trials), "Other" (230 trials), "Biological" (139 trials), "Procedure" (105 trials) and "Radiation" (96 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (114 trials), "Quality-of-Life Assessment" (72 trials), "Questionnaire Administration" (55 trials), "Cyclophosphamide" (50 trials) and "Carboplatin" (42 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Oakland" are 385 trials for "All" genders, 63 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Oakland". undefined are not yet recruiting, 85 are recruiting, 166 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 186 completed trials in Kaiser Permanente-Oakland, 6 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Oakland, 10 "Phase 1" clinical trials were conducted, 156 "Phase 2" clinical trials and 240 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 34 trials that are defined as “Not Applicable".

Kaiser Permanente-Oakland has several departments that took part in Clinical trials: "Kaiser Permanente Medical Center - Hayward" - 60 trials